Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Irwin

Showing results (321-330 of 326) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 326 results.
Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.
Nature Cancer|December 30, 2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutationsAnita Villani, Scott Davidson, Nisha Kanwar, et al.
Nature Communications|September 27, 2019
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomasAna S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, et al.
JAMA Oncology|October 7, 2021
Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition SyndromesCatherine Goudie, Leora Witkowski, Noelle Cullinan, et al.
Cell|October 24, 2017
Comprehensive Analysis of Hypermutation in Human CancerBrittany B Campbell, Nicholas Light, David Fabrizio, et al.
Physical Review Letters|November 3, 2018
GW170817: Measurements of Neutron Star Radii and Equation of StateB P Abbott, R Abbott, T D Abbott, et al.
Pageof 33

Showing results (321-330 of 326) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 326 results.
Pediatric Blood & Cancer|June 13, 2025
Accelerating Drug Development for Neuroblastoma: Consensus Statement From the Third Neuroblastoma Drug Development Strategy ForumSteven G DuBois, Lucas Moreno, John Anderson, et al.
Nature Cancer|December 30, 2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutationsAnita Villani, Scott Davidson, Nisha Kanwar, et al.
Nature Communications|September 27, 2019
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomasAna S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, et al.
JAMA Oncology|October 7, 2021
Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition SyndromesCatherine Goudie, Leora Witkowski, Noelle Cullinan, et al.
Cell|October 24, 2017
Comprehensive Analysis of Hypermutation in Human CancerBrittany B Campbell, Nicholas Light, David Fabrizio, et al.
Physical Review Letters|November 3, 2018
GW170817: Measurements of Neutron Star Radii and Equation of StateB P Abbott, R Abbott, T D Abbott, et al.
Pageof 33